Fred Hassan

Mr. Fred Hassan is an Independent Director at EyePoint, Inc., a Chairman at Saghmos Therapeutics, Inc., an Independent Director at Cocrystal Pharma, Inc., an Independent Director at BridgeBio Pharma, Inc., a Founder at Caret Pharma LLC, an Independent Director at Precigen, Inc., a Chairman at IM HealthScience LLC, an Advisor at Caerus Ventures LLC, a Chairman at Caret Group LLC, a Member at The Business Council and a Non-Executive Chairman at Physician's Seal LLC.
He is on the Board of Directors at EyePoint, Inc., Cocrystal Pharma, Inc., BridgeBio Pharma, Inc. and Precigen, Inc. Mr. Hassan was previously employed as an Independent Director by Prometheus Biosciences, Inc., an Independent Director by Amgen, Inc., a Managing Director by Warburg Pincus LLC, a Non-Executive Chairman by Bausch & Lomb, Inc., an Independent Director by Time Warner, Inc., a Chairman, President & Chief Executive Officer by Merck & Co., Inc., a Chairman & Chief Executive Officer by Schering-Plough Corp., a Chairman & Chief Executive Officer by Pharmacia Corp., a Non-Executive Chairman by Avon Products, Inc., a President & Chief Executive Officer by Pharmacia & Upjohn, Inc., a Director & Executive Vice President by American Home Products Corp., a President by Wyeth-Ayerst Laboratories, a President by International Federation of Pharmaceutical Manufacturers, a Chairman by Pharmaceutical Research & Manufacturers of America, a Principal by Sandoz Pharmaceuticals Corp., and a Chairman by Theramex HQ UK Ltd. He also served on the board at Valeant Pharmaceuticals International, Inc. and Electronic Data Systems Corp.
He received his undergraduate degree from Imperial College London and an MBA from Harvard Business School.